UK researchers seeking patients for clinical trial to address rare pregnancy condition
March 20, 2026
March 20, 2026
LEXINGTON, Kentucky, March 20 -- The University of Kentucky issued the following news:
* * *
UK researchers seeking patients for clinical trial to address rare pregnancy condition
*
Researchers at UK HealthCare are now enrolling patients in the phase 3 AZALEA trial to evaluate the safety and efficacy of an investigational medication in pregnancies at risk for severe hemolytic disease of the fetus and newborn (HDFN). This study is the first of i . . .
* * *
UK researchers seeking patients for clinical trial to address rare pregnancy condition
*
Researchers at UK HealthCare are now enrolling patients in the phase 3 AZALEA trial to evaluate the safety and efficacy of an investigational medication in pregnancies at risk for severe hemolytic disease of the fetus and newborn (HDFN). This study is the first of i . . .